LINCOLNSHIRE, ILLINOIS--(Marketwire - June 17, 2008) - MonoGen, Inc. (TSX: MOG)(the "Corporation") today announced that it has successfully completed proof-of-principle in its imaging effort and has now confidently transitioned to the full product development phase of an advanced computer imaging system to aid in cervical cancer screening. MonoGen's imager will utilize proprietary technology in combination with the continued advances in computing power to provide next generation computer imaging technology to its customers.
